In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: A comparative analysis of fresh, frozen and cumulative cycle outcomes

Human Reproduction

Volumn 30, Issue 1, 2015, Pages 88-96

  Walls, M L ^a,b   Hunter, T ^a,b   Ryan, J P ^a,b   Keelan, J A ^a,b   Nathan, E ^c   Hart, R J ^a,b  

^a Fertility Specialists of Western Australia   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

IVF; IVM; OHSS; PCOS

Indexed keywords

ADULT; ARTICLE; BIOCHEMISTRY; CASE CONTROL STUDY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; EMBRYO CULTURE; EMBRYO TRANSFER; EMBRYOLOGY; FEMALE; FERTILIZATION IN VITRO; FRESH EMBRYO TRANSFER; FROZEN EMBRYO TRANSFER; HUMAN; HUMAN CELL; IN VITRO OOCYTE MATURATION; LIVE BIRTH; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; REPRODUCTIVE HEALTH; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; TREATMENT OUTCOME; COMPARATIVE STUDY; IN VITRO FERTILIZATION;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 84922423584     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu248     Document Type: Article

References (35)

1. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review. Reprod BioMed Online 2007;14:640-649
2. Belva F, Henriet S, Van Den Abbeel E, Camus M, Devroey P, Van Der Elst J, Liebaers I, Haentjens P, Bonduelle M. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum Reprod 2008;23:2227-2238
3. Blake D, Farquhar C, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev 2007, doi:10.1002/14651858.CD002118.pub3.
4. Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-Analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683
5. Chian RC, BuckettWM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 2000;15:165-170
6. Child T.Acomparison of in vitro maturation and in vitro fertilization forwomen with polycystic ovaries. Obstet Gynecol 2002;100:665-670
7. Child TJ, Abdul-Jalil AK, Gulekli B, Lin Tan S. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril 2001; 76:936-942
8. Costello MF, Chapman M, Conway U.Asystematic reviewand meta-Analysis of randomized controlled trials on metformin co-Administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 2006;21:1387-1399
9. De Vos M, De Vos C, Ortega Hrepich F, Albuz L, Guzman N, Polyzos J, Smitz P. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2011;96:860-864.e861
10. Dokras A, Sargent IL, Barlow DH. Fertilization and early embryology: human blastocyst grading: an indicator of Developmental potential? Hum Reprod 1993;8:2119-2127
11. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, Lain M, Merola M, Milani R, De Ponti E. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online 2009; 19:343-351
12. Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens J, Hesla J. A prospective randomized trial of blastocyst culture and transfer in in vitro fertilization. Hum Reprod 1998;13:3434-3440
13. Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB. Single blastocyst transfer: a prospective randomized trial. Fertil Steril 2004; 81:551-555
14. Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 2008; 14:159-177
15. Gremeau A-S, Andreadis N, Fatum M, Craig J, Turner K, McVeigh E, Child T. In vitromaturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril 2012; 98:355-360
16. Henningsen A-KA, Pinborg A, LiDegaard O, Vestergaard C, Forman JL, AnDersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril 2011;95:959-963
17. Hovatta O, Cooke I. Cost-effective approaches to in vitro fertilization: means to improve access. Int J Gynecol Obstet 2006;94:287-291
18. Junk SM, Yeap D. Improved implantation and ongoing pregnancy rates after single-embryo transfer with an optimized protocol for in vitro oocyte maturation in women with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2012;98:888-892
19. Kim M, Hong SJ, Lee JH, Min CK, Hwang KJ, Park RW. Comparison of in vitro maturation media of immature oocytes: the effectiveness of blastocyst culture media. Fertil Steril 2011;95:554-557
20. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Amongpatients treated for IVF with gonadotrophins andGnRHanalogues, is the probability of live birth DepenDent on the type of analogue used? A systematic review and meta-Analysis. Hum Reprod Update 2006; 12:651-671
21. Li HW, Lee VC, Lau EY, Yeung WS, Ho PC, Ng EH. Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries unDergoing in vitro fertilisation treatment. J Assist Reprod Genet 2013;14:14
22. Lin YH, Hwang JL, Huang LW, Mu SC, Seow KM, Chung J, Hsieh BC, Huang SC, Chen CY, Chen PH. Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes. Hum Reprod 2003; 18:1632-1636
23. LinDenberg S. New approach in patients with polycystic ovaries, lessons for everyone. Fertil Steril 2013;99:1170-1172
24. MacDougall MJ, Tan S-L, Balen A, Jacobs HS. A controlled study comparing patients with and without polycystic ovaries unDergoing in vitro fertilization. Hum Reprod 1993;8:233-237
25. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-Analyses. Eur J Obstet Gynecol Reprod Biol 2009;146:138-148
26. Mester B, Ritter LJ, Pitman JL, Bibby AH, Gilchrist RB, McNatty KP, Juengel JL, McIntosh CJ. Oocyte expression, secretion and somatic cell interaction of mouse bone morphogenetic protein 15 during the peri-ovulatory period. Reprod Fertil Dev 2014, doi: 10.1071/RD13336.
27. Mikkelsen A, LinDenberg S. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction 2001;122:587-592
28. Richani D, Wang X, Zeng HT, Smitz J, Thompson JG, Gilchrist RB. Pre-maturation with cAMP modulators in conjunction with EGF-like peptiDes during in vitro maturation enhances mouse oocyte Developmental competence. Mole Reprod Dev 2014, doi: 10.1002/mrd.2230.
29. Roque M, Lattes K, Serra S, Sola I, Geber S, Carreras R, Checa MA. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-Analysis. Fertil Steril 2013; 99:156-162
30. Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
31. Slattery MM, Morrison JJ. Preterm Delivery. Lancet 2002;360:1489-1497
32. SoDerstrom-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari A-M. Obstetric and perinatal outcome and preliminary results of Development of children born after in vitro maturation of oocytes. Hum Reprod 2006; 21:1508-1513
33. Tang H, Hunter T, Hu Y, Zhai SD, Sheng X, Hart RJ. Cabergoline for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2012, doi:10.1002/14651858.CD008605.pub2.
34. Trounson A, AnDeriesz C, Jones GM, Kausche A, Lolatgis N, Wood C. Oocyte maturation. Hum Reprod 1998;13:52-62
35. Walls M, Junk S, Ryan J, Hart R. IVF versus ICSI for the fertilization of in vitro matured human oocytes. Reprod BioMed Online 2012;25:603-607